BWG
GILD icon

Beta Wealth Group’s Gilead Sciences GILD Stock Holding History

Beta Wealth Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Buy
5,924
+302
+5% +$39.8K 0.28% 61
2026
Q1 		$784K Sell
5,622
-398
-7% -$55.7K 0.32% 52
2025
Q4 		$739K Sell
6,020
-198
-3% -$24.1K 0.3% 53
2025
Q3 		$690K Buy
6,218
+302
+5% +$34.3K 0.27% 57
2025
Q2 		$656K Sell
5,916
-1,612
-21% -$172K 0.24% 51
2025
Q1 		$844K Sell
7,528
-95
-1% -$9.8K 0.3% 43
2024
Q4 		$704K Buy
7,623
+102
+1% +$9.18K 0.31% 50
2024
Q3 		$631K Buy
7,521
+802
+12% +$61.2K 0.28% 60
2024
Q2 		$47K Buy
6,719
+193
+3% +$12.9K 0.02% 102
2024
Q1 		$478K Buy
6,526
+216
+3% +$16.6K 0.23% 68
2023
Q4 		$511K Sell
6,310
-96
-1% -$7.47K 0.27% 60
2023
Q3 		$480K Buy
6,406
+105
+2% +$8.08K 0.28% 64
2023
Q2 		$486K Buy
6,301
+1,501
+31% +$120K 0.28% 63
2023
Q1 		$398K Buy
+4,800
New +$398K 0.23% 66
2022
Q4 		– Sell
-4,100
Closed -$252K – 99
2022
Q3 		$252K Buy
4,100
+200
+5% +$12.6K 0.18% 77
2022
Q2 		$241K Buy
3,900
+300
+8% +$18.6K 0.16% 75
2022
Q1 		$214K Buy
+3,600
New +$230K 0.14% 89

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beta Wealth Group's GILD Position: Q2 2026 in Review

Beta Wealth Group increased its Gilead Sciences (GILD) stake by 5.4% in Q2 2026, buying an estimated $39.8K and bringing the position to 5,924 shares worth $748K. The position accounts for 0.28% of the portfolio, ranked #61.

Beta Wealth Group first reported a position in GILD in Q1 2022 and has held it in 17 quarters since. The position peaked at $844K in Q1 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Beta Wealth Group held 5,924 shares of Gilead Sciences worth $748K as of Q2 2026.
  • Beta Wealth Group bought 302 Gilead Sciences shares in Q2 2026, an estimated $39.8K.
  • Gilead Sciences made up 0.28% of Beta Wealth Group's portfolio in Q2 2026, its #61 holding.
  • Beta Wealth Group first reported a position in Gilead Sciences in Q1 2022 and has held it in 17 quarters since.
  • Beta Wealth Group's Gilead Sciences position peaked at $844K in Q1 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Beta Wealth Group's 13F filing for Q2 2026, filed 24 Jul 2026.